By Jenny Ruth
Wednesday 8th June 2011 |
Text too small? |
Tower's first-half underlying result of $18.7 million, excluding the $7.5 million charge relating to the Christchurch earthquake and the discount rate effect, was about $2.5 million below his expectations, says John Cairn, an analyst at Forsyth Barr.
The discount rate effect - which resulted in a $5.7 million charge - relates to valuing individual life risk policy liabilities.
Nevertheless, Tower remains in a robust financial position with net cash of $106.8 million and it expects its gross exposure to the Christchurch earthquake will be about $350 million which will be covered by its reinsurance arrangements, Cairns says.
He is leaving his forecasts unchanged until reinsuarance rates are finalised by July this year. "Once the new rates are set, Tower will attempt to recover increased reinsurance rates through higher premiums," Cairns says.
"Whilst there is ongoing uncertainty over reinsurance markets in the short term, it is important to bear in mine reinsurance markets are cyclical, traditionally following a five-year cycle," he says.
Tower is continuing to make operational improvements across its three business units and is pursuing a number of initiatives to drive organic growth, targeting cross-marketing opportunities in its branch network and tied distribution network.
"The potential divestment by GPG of its 35% stake could trigger a full or partial takeover. We see value in Tower around current levels ($1.79)." Cairns values the shares at $2.28.
Recommendation: Accumulate.
No comments yet
Tower to return 'initial' $70M of capital from sale of life business
Tower shares fall to 2-month low as licensing requirements may weigh on capital returns
Tower's licensing talks with RBNZ may push up minimum solvency requirements
Tower names Hancock as new chief executive, replacing Flannagan
Tower posts first-half profit as asset sales reap gains of $51.4 mln
Fidelity Life acquires most of Tower's life insurance business
Flannagan to leave Tower after strategic review, asset sales
Tower FY profit jumps 67%, to return $120M to shareholders; shares jump
Tower sells medical insurance unit to nib for $102M
Stiassny joins Tower board as questions linger over strategy